Drugs / Vitamin A Compound
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03870529 | Aug 2019 → Dec 2022 | non-small cell lung carcinoma | Wake Forest University Health Sciences | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vitamin A Compound | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03870529 ↗ |
| Route | Oral | “Participants receive vitamin A compound orally (PO) for 7 consecutive days” NCT03870529 ↗ |